DYDC Antibodies

Santa Cruz Biotechnology features a diverse variety of DYDC Antibodies for advanced research in molecular biology. DYDC Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DYDC, or Dipeptidyl Peptidase IV-like protein 2, plays a crucial role in regulating immune responses and metabolic processes. DYDC involvement in cell signaling pathways makes it a significant target for understanding various diseases, including diabetes and cancer. Research focused on DYDC continues to reveal new insights into its function in physiological and pathological conditions. Understanding DYDC mechanisms can lead to potential therapeutic strategies for various medical conditions. Investigating DYDC expression patterns helps identify its role in different tissue types and cellular processes. DYDC research contributes to advancing our knowledge of cellular regulation and disease progression. Santa Cruz Biotechnology monoclonal antibodies for DYDC support researchers worldwide in advancing scientific understanding and potential therapeutic developments.